ClinicalTrials.gg
RecruitingNCT07039825Updated Jun 26, 2025

AAA-CTA Cohort Registry

An observational study in Abdominal Aortic Aneurysm and Image, sponsored by RenJi Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-26.

Sponsored by RenJi Hospital · Observational

How we know

From the registry’s dates

  • Started Jan 2020; still recruiting 6 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Aortic Aneurysm, Abdominal with a site in China — 7 open to participants now, 9 under way, none of them phase 3. Aortic Aneurysm, Abdominal · China.

Started
2020
the only one that year
Observational
9 of 17
5 open now
Registered
14th of 17
by date
Lead sponsor
4 of 17
RenJi Hospital

Among the 17 studies in Aortic Aneurysm, Abdominal with a site in China, this one is the only one that started in 2020, is one of 9 observational ones, and was the 14th registered.

Aortic Aneurysm, Abdominal

467 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 99 are open to participants now.

Browse Aortic Aneurysm, Abdominal studies →

Open to participants now

7 of the 17 studies in Aortic Aneurysm, Abdominal with a site in China are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 66 Aortic Aneurysm, Abdominal studies recruiting now, 52 (79%) set no upper age limit and 3 (5%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Aortic Aneurysm, Abdominal with a site in China, or all of them as a file.
02

Study summary

The aim of this study is to investigate the measurement of abdominal aortic aneurysm by computed tomography angiography. The research will collected the results of computed tomography angiography from inpatient, emergency, and outpatient populations with abdominal aortic aneurysm.

Read the detailed description

Abdominal aortic aneurysm (AAA) is a life-threatening vascular disorder characterized by irreversible dilation of the abdominal aorta, posing a significant risk of rupture and catastrophic hemorrhage, with mortality rates reaching 65-85% upon rupture. Given the often asymptomatic nature of AAA until rupture, early detection and precise monitoring are critical to prevent fatal outcomes, underscoring the urgent need for reliable diagnostic tools.

Computed tomography angiography (CTA) has emerged as a gold-standard non-invasive imaging technique, offering high-resolution visualization of AAA morphology, including aneurysm diameter, wall thickness, thrombus formation, and spatial relationship to adjacent structures, which are essential for accurate diagnosis, rupture risk stratification, and surgical planning.

This study aims to investigate the precision and clinical utility of CTA in AAA measurement, with the potential to optimize screening protocols, improve intervention timing, and ultimately reduce AAA-related mortality.

By establishing standardized CTA-based assessment criteria, this research may contribute to enhanced diagnostic workflows, better patient risk stratification, and more personalized treatment strategies, thereby addressing a critical gap in vascular disease management.

03

Conditions studied

  • Abdominal Aortic Aneurysm
  • Image
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with abdominal aortic aneurysm undergoing computed tomography angiography

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients with abdominal aortic aneurysm who visited the study hospital.
  2. Patients included should have computed tomography angiography data.

Exclusion criteria

Exclusion Criteria:

1. Patients who declined participation, cases with incomplete or missing clinical data.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
1,000 participants (estimated)
Patient registry
No

Interventions

  • OtherComputed tomography angiography

    The results of computed tomography angiography on abdominal aortic aneurysm are collected.

06

What researchers measure

Primary outcomes

  1. Maximal abdominal aortic diameter

    The images of computed tomography angiography on abdominal aortic aneurysm are collected and the maximal diameter of abdominal artery is measured by medical specialists.

    Time frame: 1 month

Secondary outcomes

  1. Rupture

    The images of computed tomography angiography on abdominal aortic aneurysm are collected and the rupture of AAA is judged by medical specialists.

    Time frame: 1 month

  2. Mortality

    The death of AAA patients is recorded and mortality is calculated.

    Time frame: 1 month

  3. Other characteristics of AAA morphology

    Through CTA images, the existence of ulcer, mural thrombus is judged, and the length of AAA is measured by medical specialists.

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2020 (actual). Primary completion is estimated for May 2027, 88 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2025
First posted
Jun 26, 2025
StartActual
Jan 1, 2020
Primary completionEst.
May 1, 2027
CompletionEst.
May 1, 2027
Last update
Jun 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07039825
Lead sponsor
RenJi Hospital
Responsible party
Sponsor
First posted
Jun 26, 2025
Start date
Jan 1, 2020
Primary completion
May 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Jun 26, 2025

Study contacts

Jun Pu, MD, PhD
Contact
pujun310@hotmail.com
86-21-68383477

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion